Concepedia
Statistics
Publications
2
Citations
25
H-Index
Active since
2018
Affiliations
Cancer Center of Kansas(Current)
Medical College of Wisconsin
The University of Texas MD Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Roswell Park Comprehensive Cancer Center
M. Nabeel Rajeh is an author at Cancer Center of Kansas specializing in refractory myelodysplastic syndrome, medicine, and pharmacotherapy.
Publications per year
2018–2019
Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety Results in HMA Treatment Naïve & Relapsed (Rel)/Refractory (Ref) Patients
Shyamala Navada, Guillermo Garcia‐Manero, Ehab Atallah et al. · Blood · 2018 · 14 citations
Medicine, Pharmacology, Pharmacotherapy +13
Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
Shyamala Navada, Guillermo Garcia‐Manero, Ehab Atallah et al. · Blood · 2019 · 11 citations
Medicine, Pharmacology, Pharmacotherapy +15
1–2 of 2